Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal by Indrajit Banerjee et al.
Banerjee et al. BMC Psychiatry 2013, 13:96
http://www.biomedcentral.com/1471-244X/13/96RESEARCH ARTICLE Open AccessSocio demographic profile and utilization pattern
of antipsychotic drugs among schizophrenic
inpatients: a cross sectional study from western
region of Nepal
Indrajit Banerjee1*, Bedanta Roy2, Brijesh Sathian3, Indraneel Banerjee4, Prasanta Kumar Chakraborty5
and Archana Saha6Abstract
Background: Currently a large number of atypical antipsychotics available in the market are endorsed as better
option for treating schizophrenia than the typical antipsychotics. Information regarding the utilization pattern of
antipsychotic drugs is lacking in Nepalese population particularly in Western Nepal. By means of this study one is
expected to acquire an idea concerning clinician’s preference to the antipsychotic drugs in actual clinical setup. The
main objective of the study was to find the commonest antipsychotics prescribed in a tertiary care center among
hospitalized patients in Western Nepal.
Methods: This cross sectional study was carried out between 1st January 2009 and 31th December 2010 at
Manipal Teaching Hospital, Nepal. The diagnosis of schizophrenia was based on ICD-10 (Tenth revision).The main
outcome variables of the study was commonest antipsychotic drug prescribed. Z test, Chi square test and logistic
regression were used for analytical purpose. P-value < 0.05 was considered to be statistically significant. This is the
first study done on the utilization pattern of antipsychotics drugs among hospitalized patients in Nepal.
Results: Out of 210 cases of schizophrenia, most of the patients were less than 40 yrs. 78.6%, male 61.9%,
unemployed 86.7% and having their monthly income less than NPR 10000 /month 80.5%. As far as religion, 78.1%
patients were the Hindus and ethnically schizophrenia was common among the Dalit 26.2%. The study revealed
that 46.2% of patients were students followed by 25.2% of housewives. Olanzapine was the commonest
antipsychotic drug to be prescribed 34.3%. It was observed that the psychiatrists had a tendency of using
antipsychotic drugs by trade names [OR 3.3 (1.407, 8.031)] in male patients as compared to female patients.
Conclusion: According to the utilization pattern of antipsychotics, it is concluded that atypical antipsychotics were
used relatively more commonly than that of typical antipsychotics. Among the atypical antipsychotic drugs, there is a
trend of using Olanzapine during Schizophrenia as compared to other atypical antipsychotic drugs in Western Nepal.
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According to WHO, Drug utilization study is defined as a
study of marketing, distribution, prescription and uses of
drugs in a society highlighting on the resulting medical, so-
cial and economic consequences [1]. Medical aspects focus
on the need to balance between the risk and the benefits.
The benefits are assessed on the basis of drug efficacy in
preventing, relieving and curing diseases or their symp-
toms and complications. Potential risks include short term
and long term adverse effects involving special risk factors
mainly associated with genetics, disease, environment, nu-
trition, age, sex, pregnancy, lactation. A social aspect pri-
marily deals with impact of drugs in the society. It focuses
on the attitudes of people towards drug use, and current
trends of treatment verses insistent use of conventional
medicines. The practice of drug abuse and subsequent
causes are also essential social components. Economic as-
pect reflects on the prices and the applicable heath benefits
of a given drug. This includes the drug prices, import
verses local products and the costs of drug treatment
verses non drug treatment. Current and future allocation
of national resources to the drug and health budget is also
an economic component [2]. Drug utilization research af-
fords a baseline reference point about the effect of diverse
interventions on prescribing the concerned drugs.
Globally the prevalence of schizophrenia shows a wide
range of differences [3]. It is estimated that the median
prevalence of schizophrenia is 4.6/1,000 for point preva-
lence, 3.3/1,000 for period prevalence, 4.0/1000 for life-
time prevalence and 7.2 for lifetime risk of morbidity
across the world [4]. A study conducted by Robin RW
et al. reports that globally the lifetime prevalence of
schizophrenia is 1% [5]. According to standardized mortal-
ity ratio, the individuals with a complaint of schizophrenia
have a 2-3-fold increased mortality risk as compared with
the general population [6,7].
Evidently, there is a dearth need of relevant literatures
concerning schizophrenia in Nepal as there is no adequate
research about it. A recent study conducted at psychiatric
clinic in Janakpur, Nepal showed high prevalence of
schizophrenia (30%) [8]. Similar nature of result was found
in a tertiary care mental hospital in Kathmandu, Nepal.
The research finding stated schizophrenia (50.1%) as a
common psychiatric disorder [9] whereas a study from Jiri,
Eastern Nepal revealed low prevalence of schizophrenia
(1.4%). Comparatively, this figure is quite small as com-
pared to other psychiatric disorders [10]. Studies have
shown that the outcome of schizophrenia is better in de-
veloping countries [11]. Following the recent evidences of
a systemic review and Meta-analysis on antipsychotics
among adults with schizophrenia, it has shown that the
benefits of atypical antipsychotics over typical antipsy-
chotics remain indecisive because of discrepancy in
assessing the result [12]. A study carried out in Nepalindicates that both atypical and typical antipsychotics were
effective to reduce the psychopathological symptoms of
schizophrenia among Nepalese population. Interestingly,
the finding of this study is contradictory to another study
which revealed that atypical antipsychotics like Risperi-
done has quicker and better safety profile than typical an-
tipsychotics like Haloperidol [13]. Nepalese population
includes a wide variety of ethnic groups, to name a few,
the Brahmin, Chettri, Gurung, Newar, Puns, Magar [14].
The level of knowledge and information with regard to
the utilization pattern of antipsychotic drugs among
Nepalese population is far less than present requirement.
A 2001 study conducted by Shankar PR et al. at outpatient
department of Psychiatry in Western Nepal confirms that
the utilization pattern of antipsychotics was very low 8.6%
as compared to other psychotropic drugs like antidepres-
sants 45.94%, anxiolytics 19.41% [15].
The main objective of the study was to find out the
commonest antipsychotics prescribed for patient with
schizophrenia among hospitalized patients in western
Nepal. The specific objectives were to find out whether the
antipsychotics were prescribed by generic or trade names,
essential or nonessential drugs, drug therapy or combin-
ation of drugs and psychotherapy, groups of antipsychotics
prescribed, socio demographic details of schizophrenic pa-
tients in Nepalese context. This is the first study under-
taken in the utilization pattern of antipsychotics among the
hospitalized patients in Nepal.
Methods
Study design and the participants
The present study was a cross sectional study done at
Manipal teaching hospital, Pokhara, Nepal. It is a tertiary
care hospital of Western Nepal and has been providing
services to patients from 1998 onwards. It was expected
that all the critically ill psychiatric cases with schizo-
phrenia will report at this hospital Western Nepal.
Data collection
The study was carried out between 1st October 2009 and
30th September 2010 at Psychiatric ward in Manipal Teach-
ing hospital. The collected data include socio demographic
details such as age (<40 years and >40 years), gender (male
and female), occupation (housewife, teacher, laborer, stu-
dent, farmer, retired and others), religion (Hindu, Buddhist,
Muslim), ethnicity (Brahmin, Chettri, Newar, Dalit and
others), employment (employed and unemployed), monthly
income NPR (<10000/month and >10000/month, groups
of drugs (miscellaneous comprising of both typical and
atypical antipsychotics combined together, atypical anti-
psychotics, typical antipsychotics) Treatment (ECT, drug
therapy, drug and psychotherapy combined, based on es-
sential drug list (essential or non-essential), trade/generic,
commonest antipsychotic drug. Anatomical Therapeutic
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prescribed [16].
Inclusion criteria
The study conducted between 1st October 2009 - 30th
September 2010, includes 210 cases of critical ones with all
types of schizophrenia but there was no age limit of the pa-
tients. The diagnosis of the disease was based on ICD-10
(Tenth revision) Classification of mental and behavioral
disorders, Diagnostic Criteria for Research [17,18]. The
total number of cases includes inpatient psychiatric cases
and those were both inpatient and outpatient.
Exclusion criteria
Out of 565 psychiatry inpatients, 355 patients were ex-
cluded following the diagnosis of psychiatric disorder as
the study requires the participation of patients who are
suffering from Schizophrenia only. Other additional
cases, namely depression, anxiety, mania, bipolar dis-
order, substance abuse, suicidal tendencies and mental
retardation were excluded from the study. The out pa-
tients were also excluded as the research aims to study
about the drug utilization pattern among the patients
who were critically ill with schizophrenia.
Sample size calculation
For 95% confidence interval and, significance level α = 5%,
P = 90%, Q = 10%, allowable error = 5%, required sample
size was 171. P = percentage of antipsychotic drugs used
for the treatment of Schizophrenia. In the pilot study done
prior to the original study with 10 patients was admitted
in the psychiatry ward with Schizophrenia [18].
Outcome variable
The main outcome variable was the commonest anti-
psychotic drug prescribed.
Explanatory variables
The demographic and psychiatric disorders have been
defined at individual level. Factors which are taken into
account at individual level were Age (<40 years and >40 -
years), gender (male and female), monthly income
(<10000/month and >10000/month), employment of the
patient (employed and unemployed), occupation (house-
wife, laborer, student, farmer, retired and others), reli-
gion (Hindu, Buddhist, Muslim), ethnicity (Brahmin,
Chettri, Newar, Dalit and others).
Ethical committee approval
Prior the study, ethical committee approval was taken
from the institutional ethical committee, Manipal Teach-
ing hospital, Pokhara, Nepal. The Research was conducted
in accordance to latest version of the Declaration of
Helsinki.Data management and statistical analysis
The data collected was analyzed using Excel 2003, R 2.8.0
Statistical Package for the Social Sciences (SPSS) for
Windows Version 16.0 (SPSS Inc; Chicago, IL, USA) and
EPI Info 3.5.1 Windows Version. The Z test and chi
square test was used to observe the difference between dif-
ferent variables and strength of the relationship with logis-
tic regression. p < 0.05 was considered as statistically
significant. We calculated odds ratios (OR) and their 95%
confidence intervals (95% CI). p < 0.05 was considered as
statistically significant [19].
Results
Socio demographic background of schizophrenia
Among 210 schizophrenia patients, 78.6% were of younger
age and less than 40 yrs, 61.9% male, 86.7% unemployed
and 80.5% of them having monthly income less than
10000 NPR /month. As far religious background is
concerned, most of the patients were Hindus 78.1%
followed by Buddhist 15.2%, Christian 3.8% and Muslims
2.9%. However, the majority of patients of schizophrenia
were from Dalit communities 26.2% followed by the
Chettri 23.8%. It was also found that 46.2% of the patients
were students, housewife 25.2% and others 8.6%, retired
6.7%, job holders 5.7% respectively (Table 1).
Schizophrenia and antipsychotic drugs
Data indicated that most of the schizophrenic patients had
been receiving antipsychotics by trade names. Nearly
65.4% of schizophrenic male patient had received drugs by
trade names which was found to be statistically significant
p < 0.01. Though Nepal has essential list of drugs, most of
the patients of schizophrenia had received drugs which
are not listed there. An association was noticed between
the ethnicity and the practice of using drugs from the Na-
tional drug list of Nepal (p = 0.0001), it was revealed that
drugs which were not included in the national drug list of
Nepal were also commonly used in the Dalit 26%, Chettri
24.7%, Brahmin 12%, Gurung 12.7%, Newari 9.3%, Magar
and Pun 4%, others 11.3% (Table 2).
Table 3 shows cross tabulation information namely
socio demographic factors, groups of antipsychotic drugs
and the type of treatment given to the schizophrenic pa-
tients. Most of the patients received atypical antipsy-
chotics among antipsychotics. There was an association
among ethnicity, occupation and religion of the patients
with the groups of antipsychotics prescribed. Data shows
that 65.5% patients were Hindus followed by Buddhist
20.2, Christian 6.5% and Muslims 4.8% received atypical
antipsychotic drugs. Ethnically, atypical antipsychotics
drugs were consumed by 22.6% of Dalit patients, 26.6%
Chettri patients, 9.7% Brahmin patients, 15.3% Gurung
patients, Magar and Pun 4.8% and Newar 9.7%. Likewise,
48.4% of patients were students followed by housewife.
Table 1 Cross tabulation between socio demographic
factors and schizophrenia in psychiatry inpatients
Socio demographic factors P Value 95% CI
Age
> 40 yrs 45(21.4) 0.0001† [16.1, 27.6]
<40 yrs 165(78.6) [72.4, 83.9]
Gender
Female 80(38.1) 0.0001† [31.5, 45.0]
Male 130(61.9) [55.0, 68.5]
Employment
Employed 28(13.3) 0.0001† [9.0, 18.7]
Unemployed 182(86.7) [81.3, 91.0]
Monthly income
>10000/month 41(19.5) 0.0001† [14.4, 25.5]
<10000/month 169(80.5) [74.5, 85.6]
Religion
Muslim 6(2.9) - [1.1, 6.1]
Christian 8(3.8) [1.7, 7.4]
Buddhist 32(15.2) [10.7, 20.8]
Hindu 164(78.1) [71.9, 83.5]
Ethinicity
Magar, Pun 11(5.2) - [2.6, 9.2]
Others 17(8.1) [4.8, 12.6]
Newar 17(8.1) [4.8, 12.6]
Gurung 21(10) [6.3, 14.9]
Brahmin 39(18.6) [13.6, 24.5]
Chettri 50(23.8) [18.2, 30.2]
Dalit 55(26.2) [20.4, 32.7]
Occupation
Labourer 8(3.8) - [1.7, 7.4]
Farmer 8(3.8) [1.7, 7.4]
Job holder 12(5.7) [3.0, 9.8]
Retired 14(6.7) [3.7, 10.9]
Others 18(8.6) [5.2, 13.2]
Housewife 53(25.2) [19.5, 31.7]
Student 97(46.2) [39.3, 53.2]
† p<0.01, statistically significant.
-P value cannot calculate.
Banerjee et al. BMC Psychiatry 2013, 13:96 Page 4 of 10
http://www.biomedcentral.com/1471-244X/13/96Schizophrenic patients received various types of treat-
ment like ECT, drug and psychotherapy combined to-
gether. Most of the patients received a combination of
drug therapy and psychotherapy. It was found that there
was an association among different factors namely age,
monthly income, religion and occupation and subse-
quent treatment given to the patients, which showed
that 87.9% patients less than 40 years of age received a
combination of psychotherapy and drug therapy whereas
if the age of the patient was over 40 years they received
drug therapy only. Religious background also indicates,
there were 70.1% and19.6% Hindus and Buddhists re-
spectively. Likewise, 40% Dalit were followed by Chettri
24.3% and Brahmin 19.6%. 46.7% were students followed
by housewives 28% received a combination of both psy-
chotherapy and drug therapy.
The most common antipsychotic drug prescribed was
olanzapine. There was an association between the age of
the patient and antipsychotics prescribed (p = 0.001). It
was revealed if the age is <40 years, Olanzapine wasprescribed to 84.7% patients but if the age of the patient
is > 40 yrs. Risperidone was commonly prescribed 45.9%
(p = 0.002) (Table 4).
Commonest antipsychotics prescribed
Olanzapine (Atypical Antipsychotics) was the commonest
antipsychotic drug prescribed 34.3% followed by Halo-
peridol (Typical Antipsychotics) 28.6%, combination of
haloperidol and olanzapine 12.4%, Risperidone 17.4%,
clozapine 3.8%, Quetiapine 2.4% and Aripiprazole 1%
(Atypical Antipsychotics ) respectively.
Determinants of antipsychotics use by logistic regression
From the point of view of logistic regression analysis, it
was found that Psychiatrist has a [OR 7.9, 95% (CI 1.209,
51.84)] more tendency of prescribing medicines not
from the essential drug list Nepal if the patient is from
Gurung community as compared to Magar and Pun.
Psychiatrist has 6.0 and 4.6 times more tendency of pre-
scribing medicines not from the essential drug list of
Nepal among students [OR 6.0(95% (1.332, 27.324)] and
housewives [OR 4.6(95% (0.979, 22.010)] respectively. It
is also observed that the tendency of using antipsychotic
drugs by trade names were [OR 3.3 (1.407, 8.031] times
more among male patients as compared to female ones.
All the findings were statistically significant (Table 5).
Discussion
Socio-demographic details and schizophrenia
In the course of research, it was noticed that out of 210
cases of Schizophrenia, 58.76% of the cases involved
males followed by 41.24% of females. The data shows
that this finding resembles a research study conducted
in Bangladesh as there also males suffer more with psy-
chiatric disorder as compared to females [20]. However,
this finding is different from a study done in Australia
by Mant A et al. as it shows that Psychiatric illness is
more common among female patients [21]. Most of the
patients with Schizophrenia were below 40 years of age
78.6%, whereas only 21.4% of the patients were over 40 -
years. Similar nature of finding was reported by Maki P
et al. that schizophrenia is commonly prevalent among
the adolescence [22]. Most of the patients of Schizophre-
nia were Hindus 78.1%, followed by Buddhists 15.2%,
Christians 3.8% and Muslims 2.9% respectively. This
could be due to the fact that Nepal is Hindu dominated
country and obviously most of the patients are expected
to be from Hindu religion. Ethnically, most of the pa-
tients were Dalit 26.2% followed by Chettri 23.8%,
Brahmin 18.6%, Gurung 10%, Newar 8.1%, Magar and
Pun 5.2% and others 8.1%. The finding of present study
is parallel to a study carried out by Kohrt BA in Nepal
as the findings of the research stated that Psychiatric
disorder is more common among Dalit/Nepali [23].
Table 2 Cross tabulation between socio demographic factors, national drug list of Nepal, generic and trade names
Socio demographic factors National drug list of Nepal Generic/trade
Essential drugs Nonessential drugs Generic Trade
Age > 40 yrs 14 (23.3) 31 (20.7) 5 (20) 40 (21.6)
<40 yrs 46(76.7) 119(79.3) 20(80) 145 (78.4)
P Value 0.400× 0.545×
Gender Female 21(35) 59(39.3) 16 (64) 64(34.6))
Male 39(65) 91(60.7) 9(36) 121(65.4)
P Value 0.336× 0.005†
Employment Employed 10(16.7) 18(12) 3(12) 25(13.5)
Unemployed 50(83.3) 132(88) 22(88) 160(86.5)
P Value 0.246× 0.565×
Monthly income >10000/month 13(21.7) 28(18.7) 7(28) 34(18.4)
<10000/month 47(78.3) 122(81.3) 18(88) 151(81.6)
P Value 0.375× 0.565×
Religion Muslim 0 (0) 6 (4) 0 (0) 6(3.2)
Christian 0(0) 8(5.3) 0(0) 8 (4.3)
Buddhist 7(11.3) 25(16.7) 2(8) 30(16.2)
Hindu 53(88.3) 111(74) 23(92) 141(76.2
P Value 0.059× 0.312×
Ethnicity Magar, Pun 5 (8.3) 6 (4) 2(8) 9 (4.9)
Others 0(0) 17(11.3) 0(0) 17(9.2)
Newar 3(5) 14(9.3) 3(12) 14(7.6)
Gurung 2(3.3) 19(12.7) 0(0) 21(11.4)
Brahmin 21(35) 18(12) 4(16) 35(18.9)
Chettri 13(21.7) 37(24.7) 10(40) 40(21.6)
Dalit 16(26.7) 39(26) 6(24) 49(26.5)
P Value 0.0001† 0.154×
Occupation Labour 5 (8.3) 3 (2) 0(0) 8 (4.3)
Farmer 2(3.3) 6(4) 0(0) 8 (4.3)
Jobholder 3(5) 9(6) 3(12) 9 (4.9)
Retired 7(11.7) 7(4.7) 0(0) 14(7.6)
Others 8(13.3) 10(6.7) 2(8) 16(8.6)
Housewife 14(23.3) 39(26) 10(40) 43(23.2)
Student 21(35) 76(50.7) 10(40) 87(47)
P Value 0.053× 0.190×
† p<0.01, statistically significant.
× p>0.05, statistically not significant.
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monthly income less than 10000 NPR /month (80.5%)
and unemployed patients (86.7%). This finding is analo-
gous to the outcome of study done in Sweden by Lessen
E et al. as the data showed that utilization of psycho-
tropic drugs were more among individuals with low
income [24]. Similarly, different researched findings con-
firmed that schizophrenia appears to have socioeco-
nomic and racial dimensions. It is most commonly seen
amongst the poor in the United States, England, Japan,
Norway, Ireland and Iceland, but in the context of India
and possibly in Italy it is more frequently witnessedamong the rich. The disease is also common among
urban dwellers and blacks in the United States [25]. As
far as occupation of the patients is concerned, Schizo-
phrenia was most commonly seen among students
46.2% followed by housewives 25.2%, others 8.6%
followed by retired persons 6.7%, jobholders 5.7%,
farmers and labours 3.8%. This is similar to the conclu-
sion of research done by Banerjee et al. as it revealed
that psychiatric disorders in Nepal found among house-
wives and students [26,27]. In a study from Bangladesh
also reported that psychiatric disorder is common
among students and housewives [20].
Table 3 Cross tabulation between socio demographic factors, groups of anti-psychotics, treatment given to the
schizophrenic inpatient at the psychiatric ward









Age >40 yrs 3(11.5) 14(23.3) 28(22.6) 2(100) 13(12.2) 27(36) 3(11.5)
<40 yrs 23(88.5) 46(76.7) 96(77.4) 0(0) 94(87.9) 48(64) 23(88.5)
P value 0.419× 0.0001†
Gender Female 21(80.8) 39(65) 70(56.5) 2(100) 44(41.1) 29(38.7) 5(15.4)
Male 5(19.2) 21(35) 54(43.5) 0(0) 63(58.9) 46(1.3) 21(80.8)
P value 0.057× 0.05×
Employment Employed 2(7.7) 10(16.7) 16(12.9) 0(0) 18(16.8) 8(10.7) 2(7.7)
Unemployed 24(92.3) 50(83.3) 108(87.1) 2(100) 89(83.2) 67(89.3) 24(92.3)
P value 0.519× 0.455×
Monthly income >10000/month 4(15.4) 13(21.7) 24(19.4) 2(100) 26(24.3) 9(12) 4(15.4)
<10000/month 22(84.6) 47(78.3) 100(80.6) 0(0) 81(75.7) 66(88) 22(84.6)
P value 0.794× 0.005 †
Religion Muslim 0(0) 0(0) 6(4.8) 0(0) 3(2.8) 3(4) 0(0)
Christian 0(0) 0(0) 8(6.5) 0(0) 8(7.5) 0(0) 0(0)
Buddist 0(0) 7(11.7) 25(20.2) 2(100) 21(19.6) 9(12) 0(0)
Hindu 26(100) 53(88.3) 85(65.5) 0(0) 75(70.1) 63(84) 26(100)
P value 0.003† 0.0001†
Ethinicity Magar, Pun 0(0) 5(8.3) 6(4.8) 2(100) 5(4.7) 4(5.3) 0(0)
Others 3(11.5) 0(0) 14(11.3) 0(0) 9(8.4) 5(6.7) 3(11.5)
Newar 2(7.7) 3(5) 12(9.7) 0(0) 8(7.5) 7(9.3) 2(7.7)
Gurung 0(0) 2(3.3) 19(15.3) 0(0) 16(15) 5(6.7) 0(0)
Brahmin 6(23.1) 21(35) 12(9.7) 0(0) 21(19.6) 12(16) 6(23.1)
Chettri 4(15.4) 13(21.7) 33(26.6) 0(0) 26(24.3) 20(26.7) 4(15.4)
Dalit 11(42.3) 16(28.6) 28(22.6) 0(0) 22(40) 22(40) 11(20)
P value 0.0001 † 0.0001†
Occupation Labour 0(0) 5(8.3) 3(2.4) 0(0) 8(7.5) 0(0) 0(0)
Farmer 2(7.7) 2(3.3) 4(3.2) 0(0) 4(3.7) 2(2.7) 2(7.7)
Job holder 0(0) 3(5) 9(7.3) 0(0) 6(5.6) 6(8) 0(0)
Retired 3(11.5) 7(11.7) 4(3.2) 0(0) 7(6.5) 4(5.3) 3(11.5)
Others 2(7.7) 8(13.3) 8(6.5) 2(100) 2(1.9) 14(18.7) 2(7.7)
Housewife 3(11.5) 14(23.3) 36(29) 0(0) 30(28) 18(24) 3(11.5)
Students 16(61.5) 21(35) 60(48.4) 0(0) 50(46.7) 31(41.3) 16(61.5)
P value 0.044 * 0.0006†
†p<0.01, statistically significant.
* p<0.05, statistically significant.
× p>0.05, statistically not significant.
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Drug therapy
In most of the cases of Schizophrenia, drug therapy and
psychotherapy treatments were used together 51%;
whereas in 35.7% cases were given either typical or atyp-
ical antipsychotics alone; in 12.4% cases a combination
of multidrug were given comprising both typical and
atypical antipsychotics and ECT was used only in 1% of
the cases of schizophrenia. Psychotherapy was not used
alone in none of the cases. It showed that psychotherapyalong with drug therapy is more commonly used in
schizophrenia management.
Most of the drugs were prescribed by trade names
88.1% whereas only 11.9% of the drugs were prescribed
by generic name. This is similar to a study done in 2001
by PR Ravishankar on psychotropic drug utilization
which also shows that 71.3% of the drugs were pre-
scribed by trade names in Nepal [15]. In a different
study done in the tertiary care hospital in Nepal indi-
cates the low use of drugs by generic names in the past
Table 4 Coss tabulation between socio demographic factors and neuroleptics prescribed
Socio demographic factors Antipsychotics prescribed
Aripriprazole Quetiapine Clozapine Risperidone Haloperidol
& Olanzapine
Haloperidol Olanzapine P Value
N05AX12 N05AH04 N05AH02 N05AX08 - N05AD01 N05AH03
Age
> 40 yrs 0(0) 0(0) 0(0) 17(45.9) 3(11.5) 14(23.3) 11(15.3) 0.002†
<40 yrs 2(100) 5(100) 8(100 20(54.1) 23(88.5) 46(76.7) 61(84.7)
Gender
Female 0(0) 3(60) 3(37.5) 19(51.4) 5(19.2) 21(35) 29(40.3) 0.156×
Male 2(100) 2(40) 5(62.5) 18(48.6) 21(80.8) 39(65) 43(59.7)
Employment
Employed 0(0) 0(0) 2(25) 0(0) 2(7.7) 10(16.7) 14(19.4) 0.079×
Unemployed 2(100) 5(100) 6(75) 37(100) 24(92.3) 50(83.3) 58(80.6)
Monthly income
>10000/month 0(0) 0(0) 0(0) 9(24.3) 4(15.4) 13(21.7) 15(20.8) 0.580×
<10000/month 2(100) 5(100) 8(100) 28(75.7) 22(84.6) 47(78.3) 57(79.2)
Religion
Muslim 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 6(8.3) 0.001†
Christian 0(0) 0(0) 0(0) 3(8.1) 0(0) 0(0) 5(6.9)
Buddhist 0(0) 2(40) 8(100) 10(27) 0(0) 7(11.7) 13(18.1)
Hindu 2(100) 3(60) 0(0) 24(64.9) 26(100) 53(88.3) 48(66.7)
Ethinicity
Magar, Pun 0(0) 2(40) 0(0) 0(0) 0(0) 5(8.3) 4(5.6) 0.001†
Others 0(0) 0(0) 0(0) 3(8.1) 3(11.5) 0(0) 11(15.3)
Newar 0(0) 0(0) 0(0) 7(18.9) 2(7.7) 3(5) 5(6.9)
Gurung 0(0) 0(0) 0(0) 10(27) 0(0) 2(3.3) 9(12.5)
Brahmin 0(0) 0(0) 0(0) 2(5.4) 6(23.1) 21(35) 10(13.9)
Chettri 2(100) 3(60) 0(0) 6(16.2) 4(15.4) 13(21.7) 22(30.6)
Dalit 0(0) 0(0) 8(100) 9(24.3) 11(42.3) 16(26.7) 11(15.3)
Occupation
Labourer 0(0) 0(0) 0(0) 0(0) 0(0) 5(8.3) 3(4.2) 0.12×
Farmer 0(0) 0(0) 2(25) 0(0) 2(7,7) 2(3.3) 2(2.8)
Job holder 0(0) 0(0) 0(0) 0(0) 0(0) 3(5) 9(12.5)
Retired 0(0) 0(0) 0(0) 2(5.4) 3(11.5) 7(11.7) 2(2.8)
Others 0(0) 0(0) 0(0) 4(10.8) 2(7.7) 813.3) 4(5.6)
Housewife 0(0) 0(0) 0(0) 11(29.7) 3(11.5) 14(23.3) 25(34.7)
Student 2(100) 5(100) 6(75) 20(54.1) 16(61.5) 21(28.6) 27(37.5)
† p<0.01, statistically significant.
× p>0.05, statistically not significant.
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tions. Published evidence also has revealed by promoting
the use of drugs by trade name will increase the cost
of the therapy where other generic alternatives are
available [31].
Antipsychotic drugs that have been included in the es-
sential drug list of Nepal are Chlorpromazine, Fluphen-
azine, Haloperidol and Thioridazine [32]. Essential drugs
were used in 28.6% Schizophrenia cases, which is quite
similar to another study done by P.R Ravishankar on
utilization of psychotropic drugs concluding that only
29.48% drugs were used from essential drug list of Nepal
[15]. In a study done by Upadhyay in Nepal also shows
that the prescribing drugs from essential drug list were
low 37.09% [29]. This is a matter of concern and need to
deal with by prescriber education, training campaigns
are required to improve the therapeutic management of
the patient and ensure better quality of life [15,33].This study can serve as an outline for drug prescribing
pattern and further research is required in this direction
to improve the practice of prescribing pattern. Several
other studies also shows that drug utilization study may
be helpful for therapeutic audit and hypothesis gener-
ation for the improvement of prescribing pattern of
drugs [34].
Typical and atypical antipsychotics
As evident in the present study, most of the patients re-
ceived atypical antipsychotics 59%, typical antipsychotics
were used only in 28.6% of cases and in remaining cases
a combination of typical and typical antipsychotics were
used 12.4%. Olanzapine was the commonest anti-
psychotic drug being prescribed 34.3% followed by
Haloperidol 28.6%, combination of haloperidol and
olanzapine 12.4%, Risperidone 17.4%, Clozapine 3.8%,
Quetiapine 2.4% and Aripiprazole 1%. The finding of this
Table 5 Logistic regression table of non-essential drugs (drugs not included in the national list of essential drugs of
Nepal), trade name and socio demographic factors
Socio demographic factors Nonessential drugs TradeOdds ratio (confidence interval) Odds ratio (confidence interval)
Age
> 40 yrs 1 1
<40 yrs 1.168(0.570, 2.393)× 0.906(0.320, 2.566) ×
Gender
Female 1 1
Male 0.831(0.445, 1.549) × 3.361(1.407, 8.031)†
Employment
Employed 1 1
Unemployed 1.467 (0.634, 3.393) × 0.873(0.243, 3.132) ×
Monthly income
>10000/month 1 1







Magar, Pun 1 1
Others - -
Newar 3.889 (0.695, 21.749) × -
Gurung 7.917 (1.209, 51.841)* -
Brahmin 0.714 (0.186, 2.737) × -
Chettri 2.372 (0.618, 9.099) × -
Dalit 2.031 (0.542, 7.617) × -
Occupation
Labour 1 1
Farmer 5.0(0.584, 42.797) × -
Jobholder 5.0(0.720, 34.726) × 1.037(0.144, 7.477) ×
Retired 1.667(0.283, 9.822) × -
Others 2.083(0.378, 11.482) × 1.944(0.306, 12.350) ×
Housewife 4.643(0.979, 22.010)* 0.889 (0.165, 4.777) ×
Student 6.032(1.332, 27.324)* 1.815(0.315, 10.455) ×
†p<0.01, statistically significant.
* p<0.05, statistically significant.
× p>0.05, statistically not significant.
- P value cannot calculate.
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by Dutta et al. at Uttaranchal, India in the year 2002–
2003. His finding revealed that among the used anti-
psychotics, Olanzapine was prescribed most commonly
44.4% followed by Haloperidol 28.5%, Risperidone 9.5%,
Quetiapine 6.3%, Aripiprazole5.2%, Ziprasidone, 4.2%, and
Thioridazine 2.6% [35].
In a study done by Piparva KG et al. in India shows
that the use of atypical antipsychotic drugs are used
higher 43.83% than typical antipsychotic drug 26.32%
[36]. Similar nature of studies carried out across the
world also indicated the recent trend of use of atypical
antipsychotics [37].
The published evidence confirms that atypical antipsy-
chotics might be suitable for schizophrenic patients and
better tolerated as compared to the typical antipsychotic
drugs. The treatment pattern observed correlates withthe world wide changing trends in the treatment of
Schizophrenia [33].
In recent years, the induction of newer atypical anti-
psychotic agents like Olanzapine, Risperidone, Quetiapine
and Ziprasidone have provided a better control of symp-
toms and reduced the chances of adverse effects especially
the extrapyramidal ones in contrast with typical anti-
psychotic drugs. The newer atypical antipsychotics also
proved to be better in improving negative symptoms, cog-
nitive dysfunction and also efficacious in antipsychotic re-
sistant schizophrenia [36].
Typical antipsychotics act through Dopaminergic
pathway in the mesolimbic and mesofrontal pathway
and are associated with extrapyrimidal adverse effects by
blocking the D2 receptors in the brain. It is not seen
with the atypical antipsychotics as they act through
serotenergic pathways of brain. Atypical antipsychotics
Banerjee et al. BMC Psychiatry 2013, 13:96 Page 9 of 10
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order whereas the typical antipsychotics can only treat
the positive symptoms [38,39]. Systematic review has
shown that Olanzapine is more efficacious than other
second generation antipsychotic drugs [40].
Limitation
This research is based on the hospital study from Western
Development Region of Nepal. A multi centric hospital
based study with higher sample size will be beneficial to
assess the current trend of antipsychotics all over Nepal.
Conclusion
According to the utilization pattern of antipsychotics, it
is concluded that atypical antipsychotics were used rela-
tively more commonly than that of typical antipsychotics.
Among the atypical antipsychotic drugs, there is a trend
of using Olanzapine during Schizophrenia as compared to
other atypical antipsychotic drugs in Western Nepal.
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